Texas Scottish Rite Hospital for Children Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01903525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Texas Scottish Rite Hospital for Children

Active Ingredients

Drugs in Phase 4 Trials (1)

imiglucerase (cerezyme) (1 trial)

Drugs in Phase 1 Trials (1)

fish oil (Omegavan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Athletic Injuries (Phase 1)

Brain Concussion (Phase 1)

Brain Injuries (Phase 1)

Brain Injuries, Traumatic (Phase 1)

Gaucher Disease (Phase 4)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2